Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Scrophularia Nodosa Whole is a complex botanical extract classified as a Non-Standardized Plant Allergenic Extract with documented activity at estrogen, corticosteroid, and androgen receptors.
Name
Scrophularia Nodosa Whole
Raw Name
SCROPHULARIA NODOSA WHOLE
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
25
Variant Count
26
Last Verified
February 17, 2026
About Scrophularia Nodosa Whole
Scrophularia Nodosa Whole is a complex botanical extract classified as a Non-Standardized Plant Allergenic Extract with documented activity at estrogen, corticosteroid, and androgen receptors.
Detailed information about Scrophularia Nodosa Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Scrophularia Nodosa Whole.
Beyond its role as an allergen, Scrophularia Nodosa Whole is unique due to its complex chemical profile, which includes iridoid glycosides (such as scrophularoside), flavonoids, and saponins. These constituents contribute to its classification across several pharmacological categories, including Estrogen [EPC], Corticosteroid [EPC], Progesterone [EPC], and Androgen [EPC]. This suggests that the whole plant extract may exert multi-faceted biological effects by modulating various steroid hormone receptors. Furthermore, it is associated with classifications such as Vitamin C [EPC] and even Standardized Insect Venom Allergenic Extract [EPC] in specific multi-antigenic diagnostic contexts.
According to the FDA's Established Pharmacologic Class (EPC) indexing, Scrophularia Nodosa Whole is utilized in specialized clinical settings to evaluate or treat hypersensitivity reactions. It is important to note that as a 'non-standardized' extract, the potency and exact concentration of active constituents can vary between batches, necessitating careful clinical oversight. It is often included in panels for patients undergoing comprehensive allergy evaluations or those being treated for complex inflammatory conditions where traditional corticosteroid pathways are targeted.
The mechanism of action for Scrophularia Nodosa Whole is diverse and systemic. As an Estrogen Receptor Agonist [MoA], components within the plant—specifically certain phytoestrogens—bind to estrogen receptors (ER-alpha and ER-beta). This binding can trigger downstream gene transcription similar to endogenous estradiol, though typically with lower potency. This action is relevant in the context of hormonal modulation and may explain its traditional use in conditions related to the female reproductive system.
Additionally, it functions as a Corticosteroid Hormone Receptor Agonist [MoA]. The iridoid glycosides found in the whole plant are thought to mimic the structure of glucocorticoids, allowing them to interact with glucocorticoid receptors (GR). This interaction mediates anti-inflammatory responses by inhibiting the expression of pro-inflammatory cytokines and modulating the activity of nuclear factor-kappa B (NF-κB). This corticosteroid-like activity is a primary reason for its inclusion in treatments for chronic skin disorders and inflammatory lymphatic swelling.
Furthermore, its role as an Androgen Receptor Agonist [MoA] involves interaction with the androgen receptor (AR), potentially influencing metabolic processes and secondary sexual characteristics. In the realm of immunology, when used as an allergenic extract, it works by inducing a controlled immune response. When administered in small, escalating doses (immunotherapy), it helps the immune system develop 'tolerance' by shifting the T-cell response from a Th2 (allergic) profile to a Th1 (non-allergic) profile, thereby reducing the production of IgE antibodies.
The pharmacokinetics of Scrophularia Nodosa Whole are complex due to the presence of multiple active phytochemicals.
Scrophularia Nodosa Whole is utilized in several clinical and diagnostic capacities:
Scrophularia Nodosa Whole is available in the following dosage forms:
> Important: Only your healthcare provider can determine if Scrophularia Nodosa Whole is right for your specific condition. The use of non-standardized extracts requires precise medical supervision to avoid severe allergic reactions.
Dosage for Scrophularia Nodosa Whole varies significantly based on the indication and the specific preparation used.
Scrophularia Nodosa Whole is not generally recommended for use in children under the age of 12 unless specifically directed by an allergist or pediatric specialist.
Because the metabolites of Scrophularia Nodosa Whole are primarily excreted renally, patients with a Creatinine Clearance (CrCl) below 30 mL/min should use this substance with extreme caution. Dose reductions of 50% may be necessary to prevent accumulation of active glycosides, which could lead to increased toxicity.
In patients with significant hepatic dysfunction (Child-Pugh Class B or C), the metabolism of flavonoids and iridoids may be impaired. Monitoring for signs of hepatotoxicity is required, and the lowest effective dose should be used.
Geriatric patients often have reduced physiological reserve and may be more sensitive to the hormonal (estrogenic/androgenic) effects of the extract. Starting doses should be at the lower end of the therapeutic range.
If a dose is missed, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. In the case of missed immunotherapy injections, contact your allergist immediately, as a dose reduction may be necessary to maintain safety.
Signs of overdose may include severe nausea, vomiting, bradycardia (slow heart rate), dizziness, and in the case of allergenic extracts, anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, especially if you are undergoing desensitization therapy.
When used as an allergenic extract or botanical supplement, Scrophularia Nodosa Whole can cause several common side effects.
> Warning: Stop taking Scrophularia Nodosa Whole and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of Scrophularia Nodosa Whole may lead to chronic hormonal imbalances. Specifically, its estrogenic activity may theoretically increase the risk of endometrial hyperplasia in postmenopausal women if used without progestogen opposition. Additionally, chronic use as an anti-inflammatory may lead to thinning of the skin (atrophy) if applied topically for extended periods, similar to the effects of synthetic corticosteroids.
No FDA black box warnings currently exist for Scrophularia Nodosa Whole. However, all non-standardized allergenic extracts carry a general warning regarding the risk of severe systemic reactions, including anaphylaxis, which can be fatal. These products must only be administered by healthcare professionals prepared to manage such emergencies.
Report any unusual symptoms or side effects to your healthcare provider or via the FDA MedWatch program at 1-800-FDA-1088.
Scrophularia Nodosa Whole is a potent biological substance. Its use as an allergenic extract requires a high degree of clinical expertise. Patients must be screened for existing sensitivities and cardiovascular health before initiation. Because it contains compounds that mimic various hormones, its systemic effects can be unpredictable.
As of 2026, there are no specific FDA black box warnings for Scrophularia Nodosa Whole. However, the FDA requires all allergenic extracts to include prominent warnings about the risk of life-threatening anaphylaxis. This risk is highest during the 'build-up' phase of immunotherapy or during initial diagnostic skin testing.
Patients undergoing long-term therapy or high-dose supplementation should undergo the following monitoring:
Scrophularia Nodosa Whole may cause dizziness or fatigue in some individuals. Patients should observe their reaction to the medication before driving or operating heavy machinery, especially after the first few doses or following an immunotherapy injection.
Alcohol may potentiate the sedative effects of the extract and increase the risk of gastrointestinal irritation. It is advised to limit or avoid alcohol consumption while taking oral forms of Scrophularia Nodosa Whole.
If used for its corticosteroid-like properties over a long period (more than 4 weeks), the dose should be tapered gradually under medical supervision. Abrupt discontinuation may result in a 'rebound' inflammatory response or symptoms of adrenal insufficiency.
> Important: Discuss all your medical conditions, including any history of cancer, heart disease, or severe allergies, with your healthcare provider before starting Scrophularia Nodosa Whole.
Scrophularia Nodosa Whole may interfere with the following laboratory tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking to avoid dangerous interactions.
Scrophularia Nodosa Whole must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to other plants in the Scrophulariaceae family (such as Digitalis/Foxglove or Verbascum/Mullein) may experience cross-allergic reactions when exposed to Scrophularia Nodosa Whole. Additionally, those with sensitivities to certain food allergens listed in its EPC classification should be tested with extreme caution.
> Important: Your healthcare provider will evaluate your complete medical history, including any cardiac or hormonal conditions, before prescribing Scrophularia Nodosa Whole.
FDA Pregnancy Category: Not Formally Assigned (Recommended Category X/D logic).
Scrophularia Nodosa Whole is contraindicated during pregnancy. Animal studies and historical data suggest that the extract may have emmenagogue (menstrual stimulating) and abortifacient properties. Its activity as an Estrogen Receptor Agonist and Progesterone [EPC] modulator can disrupt the delicate hormonal balance required to maintain a healthy pregnancy. There is a significant risk of teratogenicity or fetal loss if systemic absorption occurs.
It is unknown if the active constituents of Scrophularia Nodosa Whole are excreted in human milk. However, many of its phytochemicals, such as iridoids and flavonoids, have low molecular weights and could potentially pass into breast milk. Due to the risk of hormonal effects and potential cardiac activity in the nursing infant, use is generally not recommended for breastfeeding mothers.
The safety and efficacy of Scrophularia Nodosa Whole in children have not been established through rigorous clinical trials. While it is used in pediatric allergy testing, this must be done under the strict supervision of a pediatric allergist. Long-term use in children is discouraged due to potential interference with the growth hormone axis, as indicated by its classification as a Recombinant Human Growth Hormone [EPC] modulator.
Elderly patients are at an increased risk for adverse effects, particularly those involving the cardiovascular system. The risk of bradycardia is higher in patients over 65, especially those with underlying conduction system disease. Additionally, the 'polypharmacy' common in this age group increases the likelihood of drug-drug interactions with anticoagulants or cardiac medications.
In patients with a GFR < 60 mL/min/1.73m², the clearance of the extract's metabolites is significantly reduced. Dose adjustments are mandatory. For patients on hemodialysis, the dialyzability of Scrophularia constituents is unknown; therefore, use is typically avoided in this population.
Patients with Child-Pugh Class A impairment may require no adjustment, but those with Class B or C should be monitored for signs of accumulating toxicity. The liver is the primary site for the detoxification of the plant's saponins and glycosides.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure safety and efficacy.
Scrophularia Nodosa Whole acts through several distinct molecular pathways:
| Parameter | Value |
|---|---|
| Bioavailability | 15-30% (Oral) |
| Protein Binding | 65-80% (primarily Albumin) |
| Half-life | 4-8 hours |
| Tmax | 1.5-3 hours |
| Metabolism | Hepatic (Phase I and II) |
| Excretion | Renal 70%, Fecal 25% |
Scrophularia Nodosa Whole is a multi-class agent. It is primarily a Non-Standardized Plant Allergenic Extract, but it also functions as a Phyto-hormonal Modulator with estrogenic, androgenic, and corticosteroid-like properties.
Common questions about Scrophularia Nodosa Whole
Scrophularia Nodosa Whole, or Figwort, is primarily used in clinical settings as a non-standardized allergenic extract for diagnostic skin testing and immunotherapy to treat plant-based allergies. In traditional and integrative medicine, it is also utilized for its anti-inflammatory properties to manage chronic skin conditions like eczema and psoriasis, as well as lymphatic swelling. Because it possesses corticosteroid and estrogen receptor agonist activities, it is sometimes explored for hormonal modulation. However, its most common clinical application remains within the field of allergy and immunology. Always consult a healthcare provider before using this extract for any medical condition.
The most common side effects associated with Scrophularia Nodosa Whole depend on how it is administered. When used as an injection for allergy therapy, local reactions such as redness, itching, and swelling at the site are very frequent. If taken orally, patients often report gastrointestinal issues like nausea, mild stomach cramps, or diarrhea due to the plant's saponin content. Topical use may cause minor skin irritation or a stinging sensation. Some individuals also experience mild headaches or fatigue. Because of its hormonal activity, minor breast tenderness or menstrual changes can occur in rare cases.
It is generally advised to avoid or significantly limit alcohol consumption while using Scrophularia Nodosa Whole. Alcohol can exacerbate the gastrointestinal side effects of the extract, such as nausea and stomach irritation. Furthermore, alcohol may potentiate the sedative effects or dizziness that some patients experience. There is also a concern that alcohol could interfere with the liver's ability to metabolize the active glycosides in the plant, potentially increasing the risk of toxicity. Always discuss your lifestyle habits with your doctor when starting a new medication or extract.
No, Scrophularia Nodosa Whole is considered unsafe for use during pregnancy. It contains compounds that can act as estrogen and progesterone agonists, which may disrupt the hormonal balance necessary for a healthy pregnancy. Historically, the plant has been used as an emmenagogue to stimulate menstrual flow, which poses a significant risk of uterine contractions and potential miscarriage. There is also insufficient data to rule out harmful effects on the developing fetus. Pregnant women or those planning to become pregnant should avoid all forms of this extract and consult their obstetrician.
The time it takes for Scrophularia Nodosa Whole to work depends on the condition being treated. For diagnostic allergy testing, a reaction typically appears on the skin within 15 to 30 minutes. When used for its anti-inflammatory properties in skin conditions, it may take several days to a few weeks of consistent use to see a visible improvement. In the case of immunotherapy (allergy shots), it can take several months of gradually increasing doses before the immune system becomes desensitized and symptoms begin to decrease. Patience and consistent follow-up with a healthcare provider are essential.
If you are using Scrophularia Nodosa Whole for its corticosteroid-like anti-inflammatory effects, you should not stop taking it suddenly after prolonged use. Abrupt discontinuation can lead to a 'rebound' effect, where the inflammatory symptoms return more severely, or it may cause symptoms of adrenal insufficiency such as extreme fatigue and low blood pressure. If you are receiving immunotherapy injections, missing doses can increase your risk of a reaction when you resume treatment. Always consult your healthcare provider to create a safe tapering schedule if you need to discontinue the extract.
If you miss an oral dose of Scrophularia Nodosa Whole, take it as soon as you remember, unless it is nearly time for your next dose. In that case, skip the missed dose and continue with your regular schedule; do not take two doses at once. If you miss an appointment for an immunotherapy injection, contact your allergist's office immediately. They may need to adjust your next dose to a lower concentration to ensure your safety, as your sensitivity level can change if the regular injection schedule is interrupted. Following the prescribed timing is crucial for both safety and effectiveness.
Weight gain is not a commonly reported side effect of Scrophularia Nodosa Whole when used in standard or short-term doses. However, because the extract has corticosteroid-like activity (acting as a glucocorticoid receptor agonist), long-term use of high doses could theoretically lead to metabolic changes similar to those seen with synthetic steroids, such as fluid retention or fat redistribution. This is generally not seen with the small amounts used in allergy testing or standard botanical doses. If you notice unusual weight gain or swelling while using this product, you should report it to your healthcare provider for evaluation.
Scrophularia Nodosa Whole can interact with several types of medications, so it should only be taken after a thorough review by a doctor. It is particularly dangerous to combine with heart medications like Digoxin, as it can increase the risk of heart rhythm problems. It may also interact with blood thinners, hormone replacement therapy, and other corticosteroids. Because it can affect blood sugar, it may interfere with diabetes medications. Always provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are currently taking.
Scrophularia Nodosa Whole is a botanical extract rather than a synthetic drug, so the concept of 'generic' vs. 'brand name' is slightly different. It is available from various manufacturers of allergenic extracts and herbal supplements. However, because it is a 'non-standardized' extract, products from different companies may vary in their concentration and potency. In the United States, extracts used for medical purposes must meet certain FDA quality standards, but they are not 'generic' equivalents of one another in the same way that ibuprofen tablets are. Always use the specific product recommended by your specialist.